Kannalife Sciences
KannaLife Sciences Inc. develops natural phyto-medical products and therapeutic agents for health, wellness, and various ailments.
Founded
2010KannaLife Sciences Inc. develops natural phyto-medical products and therapeutic agents for health, wellness, and various ailments.
Founded in 2010 by Dean Petkanas and Thoma Kikis, Kannalife Sciences Inc. is a biopharmaceutical company headquartered in Doylestown, Pennsylvania. As a subsidiary of Neuropathix, Inc., Kannalife focuses on developing natural phyto-medical products and next-generation therapeutics targeting inflammation and neurotoxicity. The company holds an exclusive license for the commercialization of the U.S. patent "Cannabinoids as Antioxidants and Neuroprotectants," granted by NIH-OTT, and aims to address significant unmet medical needs through its innovative pipeline.
Notable figures associated with Kannalife include Dr. Tage Honoré, Chairman of the Board of Advisors, and Terrence O. Tormey. The company has achieved significant milestones, such as bolstering its intellectual property portfolio with multiple patents in key European territories. Kannalife's work has had a considerable impact on the pharmaceutical industry, particularly in the realm of cannabinoid-based therapeutics, positioning it as a leader in addressing oxidative and neuro-toxic stresses from various ailments.
Companies similar to Kannalife Sciences include Neuropathix, Panacea Life Sciences Holdings, Wellcana and Pono Life Sciences.
Kannalife Sciences was founded in 2010.
Kannalife Sciences' headquarters is located in Doylestown, PA, US.
Kannalife Sciences' most recent funding round was for $3M (USD) in September 2021.
As of Sep 28, 2021, Kannalife Sciences has raised a total of $4.5M (USD).
Kannalife Sciences has 5 employees as of Feb 5, 2024.
Wellcana
